Verified source report
STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path
With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.
Share
Send this story
Share the canonical link, post it to a feed, or send it directly.
What happened
According to STAT’s source item, STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path, With the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-19T17:08:02+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path via STAT. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better pathSTAT - 2026-05-19T17:08:02+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.